Search results
Results from the WOW.Com Content Network
Plaintiffs in lawsuits involving DePuy hip replacements have claimed that the devices failed or caused dangerous complications, including tissue death and the release of metal ions into the bloodstream. Many patients have had the implants removed and undergone revision surgery.
The Attorneys General allege that DePuy engaged in unfair and deceptive practices in its promotion of the ASR XL and Pinnacle Ultamet hip implant devices by making misleading claims as to the longevity, also known as survivorship, of the metal-on-metal hip implants.
Those who have undergone hip replacement surgery with a DePuy device and suffered from complications or injuries due to design flaws, manufacturing defects or inadequate warnings may be eligible to file a lawsuit against the company and may receive a settlement.
In a DePuy Pinnacle lawsuit update, Johnson & Johnson agreed to settle nearly 6,000 hip replacement cases against their subsidiary DePuy Orthopaedics last month. The roughly $1 billion settlement will be distributed among plaintiffs who had to have their hip implant surgically removed after experiencing severe side effects because of the device.
A Texas jury recently awarded a $1 billion verdict to six plaintiffs in a bellwether trial against Johnson & Johnson (J&J) for its DePuy Pinnacle metal-on-metal hip implant devices. The verdict followed nearly two months in trial and less than a day of deliberation.
The 2015 Settlement now compensates eligible ASR patients in the United States who had surgery to replace their ASR™ XL Acetabular Hip System or ASR™ Hip Resurfacing System, known as revision surgery, through February 15, 2017.
Johnson & Johnson has agreed to pay $120 million in a 46-state settlement announced Tuesday regarding misrepresentation of the effectiveness, longevity and safety of two hip replacement products marketed by J&J artificial joint subsidiary DePuy Orthopaedics following FDA authorizations in the early 2000s. The investigation, led by the South ...
Skadden prevailed in the U.S. District Court for the District of Arizona on behalf of DePuy Orthopaedics and its parent company Johnson & Johnson (J&J) in a two-week jury trial involving claims brought by plaintiffs Michael King and his wife regarding an allegedly defective metal-on-metal hip implant.
The lawsuits against J&J involve injuries from defective products and for failure to warn of the serious risks associated with DePuy joint replacement implants.
Meyers & Flowers, a Chicago law firm concentrating in medical device litigation, announced the $2.5 billion settlement by DePuy Orthopaedics, of Johnson & Johnson, for the more than 8,000 patients suffering from defective ASR-hip replacement devices implanted in their bodies.